Description
Mignar 25 mg Tablet is an antidiabetic used in the treatment of type 2 diabetes for adults. This medicine is not recommended for use in children. It may be used in combination with other antidiabetic medicines. Patients are advised to follow strict diet and exercise regimens along with this medicine to get the best possible effect.
QUICK LINKS:
Substitutes
List of substitutes for Mignar 25 mg Tablet
Euglitol 25 mg Tablet
Abbott Healthcare Pvt. Ltd.
Glock 25 mg Tablet
Unichem Laboratories Ltd.
Glybloc 25 mg Tablet
Unichem Laboratories Ltd.
Miglit 25 mg Tablet
Biocon Ltd.
Migset 25 mg Tablet
Cipla Ltd.
Side effects
Major & minor side effects for Mignar 25 mg Tablet
- Confusion
- Dizziness and lightheadedness
- Weakness
- Shakiness or unsteady walking
- Increased bowel movements
- Stomach and abdominal pain
- Excessive air or gas in stomach
- Rash
Uses of Mignar 25 mg Tablet
What is it prescribed for?
- Diabetes Type 2
Read More
Concerns
Commonly asked questions
- Onset of actionThe amount of time required for this medicine to show its action is approximately 1 hour.
- Duration of effectThe time until which this medicine remains active in the body is not clinically established.
- Safe with alcohol?Consumption of alcohol is not recommended during treatment with Mignar 25 mg Tablet due to the increased risk of both low as well as high blood sugar levels. If your diabetes is controlled, moderate consumption of alcohol does not affect sugar levels. However, it is advised that you consult your doctor about all the potential risks and benefits of consuming alcohol during treatment with this medicine.
- Is it habit forming?No habit forming tendency has been reported.
- Usage in pregnancy?This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
- Usage while breast-feeding?This medicine is not recommended for use in breastfeeding women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.
Allergy
This medicine is not recommended for use in patients with a known allergy to miglitol.
Diabetic ketoacidosis
This medicine is not recommended for use in patients with a known history of Diabetic ketoacidosis, a life-threatening complication of diabetes mellitus.
Inflammatory bowel disease
Mignar 25 mg Tablet is not recommended for use in patients with a known history of Inflammatory bowel disease.
Intestinal Obstruction
This medicine is not recommended for use in patients with a known history of Intestinal Obstruction.
Chronic intestinal diseases
This medicine is not recommended for use in patients with a known history of Chronic intestinal diseases.
Warnings for special population
Pregnancy
This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
Breast-feeding
This medicine is not recommended for use in breastfeeding women unless necessary. Discuss all the risks and benefits with your doctor before taking this medicine.
General warnings
Low blood glucose levels
This medicine should be used with caution due to an increased risk of low blood glucose levels. This risk is especially higher in patients on other anti-diabetic medicines. Frequent monitoring of blood glucose levels is necessary during treatment with this medicine. Appropriate dose adjustments may be done based on the clinical condition.
Gastrointestinal disease
Mignar 25 mg Tablet is not recommended for use in patients with any gastrointestinal diseases like inflammatory bowel disease, colonic ulceration, partial intestinal obstruction, or any chronic intestinal disease. It is advised that you should inform the doctor about all your medical conditions before starting treatment with this medicine.
Missed Dose
Take the missed dose as soon as you remember it. If it is almost time for your next scheduled dose, skip the missed dose. Do not double the dose to make up for the missed one.
Overdose
Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol
Description
N/A
Instructions
Consumption of alcohol is not recommended during treatment with Mignar 25 mg Tablet due to the increased risk of both low as well as high blood sugar levels. If your diabetes is controlled, moderate consumption of alcohol does not affect sugar levels. However, it is advised that you consult your doctor about all the potential risks and benefits of consuming alcohol during treatment with this medicine.
Interaction with Medicine
Corticosteroids
Furosemide
Gatifloxacin
Disease interactions
Diabetic Ketoacidosis
Mignar 25 mg Tablet is not recommended for use in patients with diabetic ketoacidosis. An alternative treatment option should be considered based on the clinical condition of the patient.
Gastro-intestinal disease
Mignar 25 mg Tablet is not recommended for use in patients with inflammatory bowel disease or any chronic intestinal disease. An alternative treatment option should be considered based on the clinical condition. It is advised that you should inform the doctor about all your medical conditions before starting treatment with this medicine.
Food interactions
Information not available.
Lab interactions
Information not available.
Take Mignar 25 mg Tablet exactly as prescribed by the doctor. The dose of the medicine is likely to change based on your body's response to therapy. It is advisable to undergo blood sugar tests at regular intervals to safely use this medicine. You should always carry a sugar candy with you to overcome unexpected lowering of blood sugar levels. The schedule and duration of use should not be changed without consulting the doctor. Ensure that the course of treatment is completed. Report any adverse effects to the doctor on priority.
Miscelleneous
How it works
Mignar 25 mg Tablet works by lowering the blood sugar levels in diabetic patients.
Legal Status
Classification
Category
Alpha-glucosidase inhibitors
Schedule
Schedule H
[Internet]. 2017 [cited 7 August 2017]. Available from:
DailyMed - MIGLITOL- miglitol tablet, coated [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 7 August 2017]. Available from:
Miglitol - DrugBank [Internet]. Drugbank.ca. 2017 [cited 7 August 2017]. Available from:
Miglitol: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 7 August 2017]. Available from:
Loading related questions...
